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Efficient B Cell Responses to Borrelia hermsii Infection Depend on
BAFF and BAFFR but Not TACI
Gregory S. Dickinson,a Guizhi Sun,a Richard J. Bram,b Kishore R. Alugupallia
‹Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USAa; Department of Pediatric and
Adolescent Medicine, Mayo Clinic, Mayo Medical School, Rochester, Minnesota, USAb

T cell-independent antibody responses develop rapidly, within 3 to 4 days, and are critical for preventing blood-borne pathogens
from evolving into life-threatening infections. The interaction of BAFF, also known as BLyS, with its receptors BAFFR and TACI
on B cells is critical for B cell homeostasis and function. Using a synthetic polysaccharide antigen, it has previously been shown
that TACI is critical for T cell-independent antibody responses. To examine the role of BAFFR and TACI in T cell-independent
antibody responses to an active infection, we utilized the Borrelia hermsii infection system. In this infection system, T cell-independent responses mediated by the B1b cell subset are critical for controlling bacteremia. We found that B1b cells express
BAFFR and TACI and that the surface expression of both receptors is upregulated on B1b cells following exposure to whole B.
hermsii cells. Surprisingly, we found that TACIⴚ/ⴚ mice are not impaired either in specific antibody responses to B. hermsii or in
controlling B. hermsii bacteremia. In contrast, TACI-deficient mice immunized with heat-killed type 3 serotype pneumococcus
cells are impaired in generating pneumococcal polysaccharide-specific responses and succumb to challenge with live type 3 serotype pneumococcus, indicating that TACI is required for T cell-independent antibody responses to bacterial-associated polysaccharides. Although we have found that TACI is dispensable for controlling B. hermsii infection, mice deficient in BAFFR or
BAFF exhibit impairment in B. hermsii-specific IgM responses and clearance of bacteremia. Collectively, these data indicate a
disparity in the roles for TACI and BAFFR in primary T cell-independent antibody responses to bacterial pathogens.

H

umoral responses are central to protection against a variety of
microbial pathogens. Mature B cells that generate protective
immunity can be classified as follicular (FOB), marginal zone
(MZB), B1a, and B1b cell subsets (1). These subsets are developmentally, phenotypically, and functionally distinct. FOB cells are
critical for responding to T cell-dependent antigens, whereas
MZB, B1a, and B1b cell subsets play a dominant role in T cellindependent (TI) antibody responses. Previously, it was thought
that TI responses were short lived; however, recent studies using
several infection systems have revealed that the B1b cell subset is
capable of generating antigen-specific, long-lasting protection in a
TI fashion (2–5).
TI antibody responses develop significantly more rapidly than
T cell-dependent responses, as early as 3 to 4 days following antigen encounter, and are highly protective and, therefore, a critical
factor in controlling bacteremia. Borrelia hermsii infection is a
well-defined system in which to study bacteremia. B. hermsii is a
causative agent of tick-borne relapsing fever, which is endemic to
the western United States (6). Experimental infections via needle
inoculation in mice have been shown to recapitulate the key
pathophysiological characteristics of the human disease (7–14). B.
hermsii infection is characterized by recurrent episodes of highlevel bacteremia (⬃108 bacteria/ml blood), with each wave of bacteremia accompanied by a febrile episode. IgM, a dominant isotype in TI responses, is both necessary and sufficient for the rapid
clearance of B. hermsii bacteremia (3, 15–17). In order to evade the
adaptive immune response of the mammalian host, B. hermsii
utilizes a complex genetic expression system, which switches the
surface expression of antigenically distinct variable major proteins
(Vmp) in 10⫺4 to 10⫺3 bacteria per generation (18, 19). This system results in waves of bacteremia, with each wave associated with
an antigenically distinct bacterial population. Initially, the protective IgM responses recognize the Vmp of B. hermsii, which facili-
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tates the clearance of each individual wave of bacteremia (3, 15–
17). Although immunocompetent mice suffer multiple episodes
of bacteremia, the severity of bacteremia typically decreases in
each subsequent episode, and by 4 weeks, the bacteremia is undetectable (3, 15–17). In mice, the decrease in the severity of bacteremic episodes correlates to the gradual generation of TI IgM responses specific to factor H-binding protein (FhbA) (20, 21), an
outer membrane protein and putative virulence factor that is constitutively expressed by B. hermsii (22, 23), suggesting that the
gradual generation of IgM specific for this conserved antigenic
target may be responsible for the eventual resolution of infection.
Using the B. hermsii infection system, we have defined a major role
for B1b cells in TI immune responses (2, 3, 16, 20). Specifically, we
have found that B1b cells are the dominant B cell subset that generates anti-B. hermsii- and anti-FhbA IgM responses. Additionally, we have shown that antigen-experienced B1b cells are responsible for long-lasting protection against reinfection (3). Although
the importance of humoral immunity in the B. hermsii system has
been well defined, the mechanisms responsible for the generation
and maintenance of the B cells required for these functional responses are not known.
B cell activating factor of the tumor necrosis factor (TNF) fam-
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ily (BAFF: also known as BLyS) and a proliferation inducing ligand (APRIL) are members of the TNF superfamily that play important roles in B cell function and normal B cell homeostasis
(24). Mature B cells express receptors for BAFF and APRIL,
namely, BAFF receptor (BAFFR; also known as BR3), transmembrane activator and calcium modulator and cyclophilin ligand
interactor (TACI), and B cell maturation antigen (BCMA) (24).
BAFF binds to BAFFR, TACI, and BCMA, whereas APRIL binds to
TACI and BCMA (24). BCMA is expressed on plasma cells but not
on mature B cells and is critical for plasma cell maintenance (25).
By engaging these receptors, BAFF and/or APRIL induces the activation of the NF-B pathway and the expression of prosurvival
molecules, such as Mcl-1 and Bcl-xL (24, 26). Mice deficient in
BAFF have significantly smaller FOB and MZB cell compartments
but have a normal frequency of B1 cells (27). These findings suggest that BAFF is not required for the generation of B1 cell subsets.
However, the impairment in TI responses in these mice indicates
that the B1 cells in BAFF-deficient mice may be functionally compromised (28, 29).
NP-Ficoll (4-hydroxy-3-nitrophenyl-acetyl conjugated to Ficoll) and bacterial polysaccharides are referred to as TI type 2
(TI-2) antigens. TI-2 antigens are defined by the fact that antibody
responses to these antigens are primarily mediated by B cell antigen receptor (BCR) cross-linking, and mice defective in BCR signaling (e.g., x-linked immunodeficient; xid mice) are severely impaired in mounting a response to this type of antigens (2, 30).
Although the antibody responses required to control B. hermsii
infection are also independent of T cell help (3, 15, 31), xid mice
can mount a protective anti-B. hermsii response (31), albeit with a
delay, suggesting that in the context of an infection, TI responses
involve more complex signaling pathways in addition to BCR signaling. Previous studies revealed that mice deficient in TACI have
impaired responses to purified TI-2 antigens (32–34). To examine
whether TACI is also required for TI responses in the context of
pathogen encounters, we have utilized Staphylococcus pneumoniae
and the B. hermsii infection system.

by dark-field microscopy as described previously (3). For S. pneumoniae
challenge, 5,000 CFU of fully virulent WU-2 strain S. pneumoniae bacteria
were injected intraperitoneally. Mice were monitored daily for survival.
Immunization. For NP-Ficoll immunization, 50 g of 77-NP-loaded-Ficoll (Biosearch Technologies, Petaluma, CA) dissolved in 100 l
Dulbecco’s phosphate-buffered saline was used to immunize mice intraperitoneally (36). For pneumococcal immunizations, mice were injected
intraperitoneally with 1 ⫻ 108 encapsulated, heat-killed cells of the WU-2
strain of S. pneumoniae (36).
ELISA. The level of B. hermsii-, FhbA-, NP-, or type 3 pneumococcal
polysaccharide (PPS3)-specific IgM or IgG was determined as described
previously (3, 20, 21, 36) Specific antibody levels were interpreted as ng/l
equivalents using enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s instructions (Bethyl Laboratories, Montgomery, TX).
Flow cytometry. To determine the frequency of B cell subsets, peritoneal cavity cells were harvested from individual mice and the cell concentration was adjusted to 2.5 ⫻ 107/ml in staining medium (deficient RPMI
medium 1640 [Irvine Scientific, Santa Ana, CA] with 3% new calf serum,
1 mM EDTA). After blocking Fc receptors with 2.4G2 antibody (1 g per
106 cells), an aliquot of 25 l of peritoneal cavity cells was incubated in a
microtiter plate with appropriately diluted antibodies. Anti-IgM-fluorescein isothiocyanate (FITC) (clone 1B4B1), anti-Mac1-AF700 (clone M1/
70), anti-CD5 Pacific blue (clone 53-7.3) anti-CD19-phycoerythrin (PE)Cy7 (clone eBio1D3), anti-CD267 (TACI)-PE (clone eBio8F10-3), antiBAFFR-allophycocyanin (APC) (clone eBio7H22E16), rat IgG2a-PE isotype
control (clone eBR2a), and rat IgG1-APC isotype control (clone eBRG1)
antibodies were purchased from eBioscience (San Diego, CA); anti-B220peridinin chlorophyll protein (PerCP)-Cy5.5 (clone RA3-6B2) was purchased from Caltag (Burlingame, CA). After staining, cells were washed
twice with staining medium and the preparations were analyzed on an
LSRII (Becton, Dickinson, Mountain View, CA), using the FACS Diva
software (Becton, Dickinson). Data were analyzed using the FlowJo software program (TreeStar, San Carlos, CA).
Statistical analysis. Statistical analyses were performed using the
Prism 5 software program (GraphPad Software, Inc., La Jolla, CA). To
analyze statistical significance, the unpaired Student’s t test (two-tailed),
one-way or two-way ANOVA, and Bonferroni’s posttest or log-rank (Mantel-Cox) test were used as necessary.

MATERIALS AND METHODS

RESULTS

Mice. The Institutional Animal Care and Use Committee at Thomas
Jefferson University approved these studies. Mice were housed in microisolator cages with free access to food and water and were maintained
in a specific-pathogen-free facility. C57BL6/J (wild-type), B6.129S2Tnfsf13btm1Msc/J (BAFF⫺/⫺), and B6(Cg)-Tnfrsf13ctm1Mass/J (BAFFR⫺/⫺)
mice were purchased from Jackson Laboratories (Bar Harbor, ME).
TACI-deficient (TACI⫺/⫺) mice on a C57BL/6 background were described previously (33).
Cell culture. Peritoneal exudate cells were harvested by peritoneal
lavage, and 1 ⫻ 106 cells were plated in each well of a 12-well plate in 2 ml
of R-15 medium (RPMI 1640 [with 25 mM HEPES and L-glutamine] plus
15% heat-inactivated fetal bovine serum and penicillin-streptomycin).
Cells were stimulated with the synthetic Toll-like receptor 2 (TLR2) agonist Pam3Cys-kkkk (100 ng/ml; EMC Microcollections, Tübingen, Germany) and/or the BCR-specific agonist AffiniPure F(ab=)2 fragment goat
anti-mouse IgM, -chain specific (100 ng/ml; Jackson ImmunoResearch
laboratories, West Grove, PA). Preparation of heat-killed B. hermsii for in
vitro cell culture was performed as described previously (35).
Infections. Although B. hermsii is naturally transmitted by tick bites,
needle inoculations can deliver a defined dose of spirochetes, and such
inoculation has been shown to recapitulate the pathophysiology of relapsing fever in humans. Therefore, in this study, mice were infected intravenously via the tail vein with 5 ⫻ 104 bacteria of B. hermsii strain DAH-p1
(from the blood of an infected mouse), and the bacteremia was monitored

B1b cells express both TACI and BAFFR, which are upregulated
by TLR2 agonist and B. hermsii. B cell responses to TI-2 antigens
are dependent on TACI, which has been shown to be required for
efficient differentiation of B cells into plasma cells (32–34). The
expression of TACI, as well as that of BAFFR, has been well characterized on FOB, MZB, and B1a but not B1b subsets (37–39).
Since B1b cells are the major cell subset that mounts responses to
TI-2 antigens, such as NP-Ficoll and type 3 pneumococcal polysaccharide (PPS3), as well as B. hermsii (2–4, 36, 40), and since
TACI and BAFFR are the primary receptors for BAFF and APRIL
on mature B cells, we evaluated the expression of both TACI and
BAFFR on B1b cells. As shown previously, we found that the B1a
cell subset expressed both TACI and BAFFR (Fig. 1A). We also
found that B1b cells expressed TACI (Fig. 1A). Interestingly, the
relative level of BAFFR on B1b cells appeared to be much higher
than that of TACI.
Classical TI-2 antigens require BCR-mediated signaling,
whereas anti-Borrelia responses are dependent on both BCR- and
TLR-mediated signaling. Specifically, we have shown that protective antibody responses to B. hermsii require TLR2 (31, 35). It has
been previously shown that the surface expression of both TACI
and BAFFR on FOB, MZB, and B1a cells increases in response to
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FIG 1 Expression of TACI and BAFFR on B1 cell subsets. (A) Peritoneal cavity cells of C57BL/6 mice (n ⫽ 3) were stained with antibodies specific for surface
CD19, B220, IgM, Mac1, and CD5, as well as TACI and BAFFR or appropriate isotype controls, and analyzed by flow cytometry. Gating strategies in each plot are
indicated (arrows), and the expression of TACI and BAFFR (bold lines) and appropriate isotype controls (gray lines) is shown. Geometric mean fluorescence
intensity (MFI) values of isotype control (regular font) and TACI or BAFFR antibodies (boldface font) are shown within the plots. Data are representative of two
independent experiments. (B and C) A million peritoneal exudate cells from C57BL/6 mice were stimulated as described for 18 h, at which time cells were stained
as described above to determine TACI and BAFFR expression. (B) Representative histograms indicating TACI and BAFFR expression on B1b cells stimulated
with no agonist (gray fill), anti-BCR (gray line), TLR2 agonist (thin black line), and anti-BCR and TLR2 agonist (bold black line) are shown. Three experimental
replicates were used, and cells for each replicate were harvested from different wild-type mice. Data are representative of two independent experiments. The data
are presented as the means and standard deviations. The differences in MFI were analyzed by one-way ANOVA and Bonferroni’s multiple comparison test or
Student’s t test as appropriate (*, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍ 0.001; ns, not significant).

CpG DNA, which is a TLR9 agonist. A separate study examined
TACI expression on total B cells in response to a variety of TLR
ligands (41), but no studies to date have examined TACI and
BAFF surface expression on B1b cells in response to in vitro stimulation. Considering the importance of TLR2 in protective, TI
anti-B. hermsii antibody responses and since B1b cells are the primary subset of B cells that confer protective immunity to B. hermsii, we examined whether a TLR2 agonist could influence the expression of TACI and BAFFR on B1b cells. We found that
stimulation of B cells with anti-BCR stimulation alone, a mimic of
TI-2 antigen, did not significantly alter the levels of TACI or
BAFFR on B1b cells in vitro (Fig. 1B). We also found that exposure
to TLR2 agonist resulted in a 2-fold upregulation of TACI and
BAFFR on B1b cells compared to their levels on unstimulated cells
(Fig. 1B). Furthermore, we found that BCR stimulation significantly enhanced the upregulation of TACI and BAFFR when coadministered with TLR ligands. This led us to examine whether B.
hermsii alone would be capable of influencing TACI or BAFFR
expression on B1b cells in vitro. In fact, we found that exposure to
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intact, heat-killed bacteria was capable of significantly increasing
both TACI and BAFFR surface expression on B1b cells (Fig. 1C).
Collectively, these findings showed that the B1b cell subset expressed both TACI and BAFFR and that the surface expression of
both receptors could be influenced by exposure to TLR2 ligands
and B. hermsii cells.
Analysis of B cell subsets and anti-NP-Ficoll responses in
TACI-, BAFF- and BAFFR-deficient mice. Since B1b cells are the
primary responders to the prototypical TI-2 antigen NP-Ficoll, as
well as to B. hermsii (2, 4, 36, 40), we analyzed the B1b cell compartments of TACI⫺/⫺, BAFFR⫺/⫺, and BAFF⫺/⫺ mice. We found
that TACI-, BAFFR-, and BAFF-deficient mice all possessed a
comparable frequency of B1b cells, though BAFFR- and BAFFdeficient mice possessed significantly fewer B1 cells than did wildtype or TACI-deficient mice (Fig. 2A and B). Although we found
that the B1 cell compartments in TACI-deficient mice were comparable to those in wild-type mice (Fig. 2A and B), they were
severely impaired in responding to NP-Ficoll (Fig. 2C), as shown
previously (33, 42). Similarly, while BAFF⫺/⫺ mice possessed a
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FIG 3 Comparable B. hermsii-specific antibody responses in wild-type and

FIG 2 Analysis of B1a and B1b cell subsets and NP-specific IgM responses in
mice deficient in TACI, BAFFR, or BAFF. (A and B) Peritoneal cavity cells of
mice were stained with antibodies specific for surface CD19, B220, IgM, CD23,
Mac1, and CD5 and analyzed by flow cytometry. All cells were first identified as
B1 cells (IgM⫹, CD19⫹ CD23⫺, and Mac1⫹ cells [plots not shown]). (A) The
frequencies of B1a (CD5⫹) and B1b (CD5⫺) subsets among those B cells are
shown. Five-percent contour plots are shown. (B) The numbers of B1a and
B1b cells in the indicated mice are shown as means ⫹ standard deviations.
These data were generated by analyzing a minimum of 20,000 cells and are
representative of at least 4 mice from each indicated genotype. Differences
between wild-type and mutant mice were determined using one-way ANOVA
followed by Bonferroni’s multiple comparison test. Data are representative of
two independent experiments. (C) Wild-type (n ⫽ 5) and BAFFR⫺/⫺ (n ⫽ 7),
TACI⫺/⫺ (n ⫽ 6), and BAFF⫺/⫺ (n ⫽ 7) mice were immunized intraperitoneally with 50 g of NP-77 Ficoll. Blood samples were obtained on days 0, 7,
and 14 postimmunization, and NP-specific IgM was determined by ELISA.
The differences in antibody responses were analyzed by two-way ANOVA with
Bonferroni’s posttest (*, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍ 0.001). Data are
representative of two independent experiments.

B1b compartment, they were severely impaired in responding to
NP-Ficoll (Fig. 2C). These data are consistent with the notion that
responses to classical TI-2 antigens depend primarily upon the
BAFF-TACI axis. There is currently no consensus regarding responses to NP-Ficoll in BAFFR-deficient mice (28, 29). We found
that BAFFR⫺/⫺ mice generated NP-specific IgM responses that
were significantly more robust than those of either TACI- or
BAFF-deficient mice but were still slightly impaired compared to
the responses of wild-type mice (Fig. 2C). The paucity of MZB and
FOB cells in BAFFR-deficient mice (28, 29) suggests that these
cells are not required for responses to TI-2 antigens, though the
impairment seen in BAFFR-deficient mice, particularly at the earliest time points, could indicate a role for MZB cells in early responses immediately following TI antigen encounter (43).
TACI is dispensable for control of B. hermsii infection. Since
TACI is required for efficient responses to TI-2 antigens (32–34)
and B1b cells play a significant role in generating TI antibody
responses against both TI-2 antigens and B. hermsii (2–4, 36, 40),
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TACI⫺/⫺ mice. (A, C, and D) Wild-type (n ⫽ 9) or TACI⫺/⫺ (n ⫽ 11) mice
were infected intravenously with 5 ⫻ 104 B. hermsii bacteria (strain DAH-p1);
bacteremia was monitored by dark-field microscopy as described previously
(3) (C), and B. hermsii-specific IgM (A) and FhbA-specific IgM (D) were
measured by ELISA. These data represent the pooled data from two independent experiments. (B) B. hermsii-specific IgG from B. hermsii-infected wildtype (n ⫽ 3) or TACI⫺/⫺ (n ⫽ 3) mice was measured by ELISA. The data
shown are representative of two independent experiments. Means ⫾ standard
deviations are shown for all panels. Differences in the antibody responses and
bacteremia were not statistically significant when analyzed by two-way
ANOVA with significance reached at a P value of ⬍0.05.

we expected that TACI would play a critical role in generating
humoral responses against B. hermsii. Surprisingly, we found that,
following infection, the kinetics of B. hermsii-specific IgM responses in TACI⫺/⫺ mice were indistinguishable from those of
wild-type mice (Fig. 3A). In response to TI-2 antigens, TACI⫺/⫺
mice generate significantly reduced IgG responses (33). Although
IgG responses are not essential for controlling B. hermsii, we also
looked at specific IgG responses to B. hermsii. We found that, like
the B. hermsii-specific IgM responses, the B. hermsii-specific IgG
responses were indistinguishable from those of wild-type mice
(Fig. 3B). Consistent with these observations, we found that the
severity of the recurrent episodes of bacteremia in TACI⫺/⫺ mice
was indistinguishable from the severity of the episodes of bacteremia in wild-type mice (Fig. 3C). We also found that the FhbAspecific antibody responses in TACI⫺/⫺ mice were comparable to
the responses found in wild-type mice (Fig. 3D). These data indicated that protective TI responses to B. hermsii did not require
TACI.
BAFF and BAFFR are required for efficient anti-B. hermsii
responses. Since we found no impairment in anti-B. hermsii responses in TACI-deficient mice, we examined a role for BAFFR
and BAFF. Following B. hermsii infection, we found that both
BAFFR⫺/⫺ and BAFF⫺/⫺ mice were significantly impaired in generating B. hermsii-specific IgM compared to wild-type mice (Fig.
4A). Consistent with this impairment, both BAFFR⫺/⫺ and
BAFF⫺/⫺ mice exhibited more-severe bacteremia than wild-type
mice at days 3 and 4 postinfection, during the primary episode
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FIG 5 Efficient responses to heat-killed PPS3-bearing S. pneumoniae cells

require BAFF, BAFFR, and TACI. Wild-type (n ⫽ 4) and BAFFR⫺/⫺ (n ⫽ 5),
TACI⫺/⫺ (n ⫽ 6), and BAFF⫺/⫺ (n ⫽ 4) mice were immunized with 1 ⫻ 108
heat-killed, PPS3-bearing S. pneumoniae cells (strain WU-2). (A) PPS3-specific IgM was measured by ELISA. Data are represented as means ⫹ standard
deviations. The differences in antibody responses were analyzed by two-way
ANOVA followed by Bonferroni’s posttest (*, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍
0.001). (B) At 28 days postimmunization, mice were infected with 5,000 CFU
of the WU-2 strain of PPS3-bearing S. pneumoniae. Survival was monitored,
and data were analyzed by log-rank (Mentel-Cox) test; only TACI⫺/⫺ and
BAFF⫺/⫺ mice exhibited significantly reduced survival (P ⬍ 0.05). Data are
representative of two independent experiments.

FIG 4 Efficient control of B. hermsii requires BAFF and BAFFR. Wild-type

(n ⫽ 18) or BAFFR⫺/⫺ (n ⫽ 12) and BAFF⫺/⫺ (n ⫽ 13) mice were infected
intravenously with 5 ⫻ 104 B. hermsii bacteria (strain DAH-p1). (A and C) B.
hermsii-specific IgM (A) and FhbA-specific IgM (C) were measured by ELISA.
Means ⫹ standard deviations are shown. Differences in the anti-B. hermsii IgM
responses of wild-type and BAFFR⫺/⫺ or BAFF⫺/⫺ mice were significantly
different from days 3 to 6 postimmunization when analyzed by two-way
ANOVA followed by Bonferroni’s posttest (A), and anti-FhbA responses of
wild-type and BAFFR⫺/⫺ or BAFF⫺/⫺ mice were significantly different at the
indicated days when analyzed by two-way ANOVA followed by Bonferroni’s
posttest (C) (*, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍ 0.001; ns, not significant). (B)
Bacteremia was monitored by dark-field microscopy as described previously
(4), and mean bacterial densities ⫹ standard deviations at indicated days
postinfection are plotted. Differences in bacteremia between wild-type and
BAFF- or BAFFR-deficient mice were determined by two-way ANOVA followed by Bonferroni’s posttest (***, P ⬍ 0.001). These data represent the
pooled data from two independent experiments.

(Fig. 4B). Specifically, the peak bacteremia in BAFFR⫺/⫺ and
BAFF⫺/⫺ mice was more than 2-fold higher than that in wild-type
mice. Additionally, the primary bacteremic episode in both
BAFFR⫺/⫺ and BAFF⫺/⫺ mice persisted for 1 day longer than was
seen in wild-type mice (Fig. 4B).
In wild-type mice, the magnitude of the recurrent episodes of
bacteremia diminished by 3 to 4 weeks postinfection. In contrast,
both BAFFR⫺/⫺ and BAFF⫺/⫺ mice exhibited persistently higher
bacteremia at these time points, though these differences were not
statistically significant and the mice were able to eventually resolve
the infection (Fig. 4B). Since specific antibody responses to FhbA
inversely correlate with the magnitude of bacteremia, we expected
that anti-FhbA responses in BAFF- and BAFFR-deficient mice
would be compromised. In fact, we found that these mice had
significantly impaired anti-FhbA responses compared to the responses in wild-type mice (Fig. 4C).
TACI is critical for protective humoral responses to heatkilled S. pneumoniae. Having found that efficient TI antibody
responses to B. hermsii did not require TACI, we set out to test
whether this difference in terms of TACI dependence in TI humoral responses is related to the difference between using analytically pure antigens, such as NP-Ficoll or purified bacterial polysaccharide, and whole pathogens, such as B. hermsii. To test this,
we utilized an S. pneumoniae strain possessing PPS3. The polysac-
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charide capsule of this pathogen typically elicits a PPS3-specific TI
humoral response in less than 1 week and is generated by B1b cells
(4). Infection in naive wild-type mice is lethal; therefore, we immunized wild-type and BAFFR-, TACI-, and BAFF-deficient mice
with heat-killed, morphologically intact S. pneumoniae (strain
WU-2). We found that the PPS3-specific IgM levels in all mutant
strains at both 7 and 14 days postinfection were significantly lower
than the levels in wild-type mice (Fig. 5A). However, at 7 days
postinfection, BAFFR-deficient mice exhibited less impairment
than either TACI- or BAFF-deficient mice. To determine the functionality of the antibody responses, we challenged the mice with
the same strain of live S. pneumoniae 28 days postimmunization
and monitored survival. We found that all TACI- and BAFF-deficient mice succumbed to the infection, while all wild-type mice
survived (Fig. 5B). In comparison, roughly half of the BAFFRdeficient mice survived, seeming to mirror the slight impairment
observed in the PPS3-specific IgM response. Collectively, these
data suggest that TACI played the dominant role in anti-PPS responses to intact heat-killed S. pneumoniae cells and that BAFFR
played a minor role in efficient responses to PPS, similar to the
role observed following immunization with NP-Ficoll (Fig. 2B).
DISCUSSION

Antibody responses to analytically pure polysaccharide antigens
are rapidly generated independently of T cell help and require
BCR cross-linking. Mice impaired in BCR-mediated signaling,
such as those deficient in Bruton’s tyrosine kinase (Btk), are severely impaired in responding to TI-2 antigens (2). While protective immune responses to B. hermsii develop independently of T
cell help, the ability of mice lacking Btk to control B. hermsii infection illustrates that the response to B. hermsii is distinct from
classical TI-2 responses. In fact, we have previously shown that, in
addition to Btk-dependent BCR signaling, Toll-like receptor
(TLR) signaling contributes to the development of efficient antibody responses to B. hermsii, illustrating that the characteristics of
TI B cell responses depend upon the immunological context in
which they are encountered (2, 31). Considering that TLR ligands
are possessed by all bacterial pathogens, including many clinically
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important bacterial species, the influence of TLRs on B cell responses to TI antigens has broad implications in the field of vaccine design.
In addition to the above-described differences, humoral responses to B. hermsii also differ from those of classical TI-2 antigens in terms of TACI dependency. While studies have demonstrated that TACI is required for efficient TI responses to
polysaccharide antigens (32, 33, 42), we find that TACI is dispensable for TI humoral responses to B. hermsii (Fig. 3). Rather, we
have found that BAFFR plays a discernible role in responses to B.
hermsii. Both BAFF- and BAFFR-deficient mice have significantly
reduced MZB cell compartments (28, 29). While MZB cells are
not required for resolution of B. hermsii infection, they have been
shown to contribute to the initial IgM response following infection (16, 44). Therefore, it is possible that the paucity of MZB cells
in these mice is partially responsible for the phenotype observed in
both BAFF- and BAFFR-deficient mice. However, in addition to
impaired initial anti-B. hermsii IgM responses, we also observed
impaired FhbA-specific IgM production and delayed resolution of
later episodes of bacteremia. Considering that the role for MZB
cells in B. hermsii infection appears limited to the first wave of
bacteremia (16), reduced MZB cell numbers do not fully explain
the observed phenotypes. Previous studies have focused on the
fact that the frequencies of B1 cells are similar in BAFFR- or BAFFdeficient and wild-type mice (27–29). We report here that while
the frequency is unchanged, the absolute number of B1b cells is
significantly lower in BAFFR-deficient than in wild-type mice
(Fig. 2B). Considering that B1b cells have been directly implicated
in B. hermsii- and FhbA-specific IgM responses, the lower numbers of B1b cells in BAFFR- and BAFF-deficient mice may explain
the observed impairments. Alternatively, it is possible that in the
absence of BAFFR signaling, B1b cells are functionally compromised. Further study will be needed to determine the precise role
of BAFFR in the B. hermsii infection system.
Humoral responses to classical TI-2 antigens, such as isolated
PPS, have been previously shown to require TACI, but considering that efficient and protective TI responses to B. hermsii occur in
the absence of TACI, we sought to determine whether TI responses generated to whole bacteria differed from responses to
isolated antigens in terms of TACI dependency. After immunizing
mice with heat-killed S. pneumoniae, we found that TACI is required for anti-PPS responses to whole heat-killed bacteria, similar to results obtained following immunization with purified PPS.
This result leads to a puzzling question: why is TACI required for
TI humoral responses to some pathogens but not others? It should
be noted that B. hermsii infection results in extremely high levels of
bacteremia, which could contribute to the ability of this infection
to activate other costimulatory pathways, such as the TLR pathway. Thus, it is possible that TLR ligand availability and persistence may vary between an active infection and immunization
with killed bacteria, resulting in a different requirement for TACImediated B cell differentiation. In fact, TACI signaling results primarily in activation of the canonical NF-B pathway (24). Therefore, it is possible that persistent TLR signaling during active
infection may bypass the need for TACI signaling through TLRmediated canonical NF-B pathway activation. Polysaccharide
vaccines have been shown to have limited immunogenicity in children and also offer a relatively short period of protection and
suboptimal boosting; understanding the ability of TLR signaling
to augment or bypass the need for TACI-mediated B cell differen-
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tiation signals could provide insights for the development of novel
immunization strategies, including improved polysaccharide vaccines.
In contrast to TI responses to polysaccharides, protective responses to B. hermsii infection have been shown to be long lived
(2, 3). This has been attributed to the long-term maintenance of
expanded populations of antigen-specific B1b cells (3, 5). BAFFRmediated signaling has been shown to play an important role in
promoting B cell survival through the production of prosurvival
molecules, such as Bcl-2 and Mcl-1, as well as kinases that are
important for metabolic fitness (24, 26). Therefore, understanding TI humoral responses that occur in the context of active infections, such as B. hermsii infection, and the importance of BAFF/
BAFFR-mediated signaling in this process could help to identify
novel strategies for improving vaccines.
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